Membrane-protein interactions play key roles in a wide variety of biological processes, including cell signaling, membrane traffi cking, blood coagulation, and viral infection, among others (1) (2) (3) . A large number of soluble proteins, both intracellular and extracellular, are known to interact with cell membranes under physiological conditions. Most of them contain lipid binding domains or motifs that mediate membrane binding either through specifi c recognition of lipid headgroups or by nonspecifi c electrostatic and/or hydrophobic interactions with membrane lipids (1) (2) (3) . More recently, it has been reported that many modular protein interaction domains, such as PDZ domains (4) (5) (6) (7) , can also directly interact with membrane [PtdIns(3)P], phosphatidylinositol-4-phosphate [PtdIns(4)P], phosphatidylinositol-5-phosphate [PtdIns(5)P], phosphatidylinositol-3,4-bisphosphate [PtdIns (3, 4) 4 ] were from Cayman Chemical. Dabsyl chloride was purchased from TCI (Portland, OR). All solvents were purchased from Sigma Chemical and Fischer Scientifi c. Triethylamine was dried by distillation from calcium hydride. Column chromatography was performed using silica gel 60 Å (32-63 mesh) purchased from Sorbent Technologies. 1 H NMR spectra were recorded with a Bruker AV-500 spectrometer. Mass spectra were obtained with a Finnigan LCQ Deca mass spectrometer under the positive ion mode.
Dabsyl-PE synthesis
POPE (50 mg, 0.07 mmol) in chloroform (2 ml) was added to a solution of dabsyl chloride (22.6 mg, 0.07 mmol) and triethylamine (0.2 ml) in chloroform (5 ml). The solution was stirred for 6 h at room temperature in the dark. The solvent was removed under reduced pressure and the residue was purifi ed by silica column chromatography (gradient elution of dicholoromethane and methanol (100:0 to 85:15) to afford dabsyl-POPE (36 mg, 0.036 mmol) as an orange solid (yield: 51%). The thin layer chromatography shows that its R f is 0.25 in acetonitrile/methanol (85:15). The structure of dabsyl-PE was confi rmed by 1 H NMR and mass spectrometry. 1 
Vesicle preparation
Lipid solutions were mixed according to the fi nal lipid composition and the solvent was evaporated under a stream of nitrogen gas. Tris buffer (20 mM, pH 7.4), containing 0.16 M NaCl was added to the lipid fi lm and the mixture was sonicated for 1 min. Large unilamellar vesicles with 100 nm diameter were then prepared with a Liposofast microextruder (Avestin) using a 100 nm polycarbonate fi lter.
Protein expression and purifi cation
All lipid binding domains were cloned into either the pET28a vector or the pRSETb vector with a C-terminus EGFP tag. Proteins were expressed in BL21 RIL cells. For expression of the proteins, 500 ml of Luria broth containing 50 g/ml kanamycin or 100 g/ml ampicillin was inoculated with BL21 RIL colonies expressing each protein construct. Cells were allowed to grow in the medium at 37°C until an absorbance at 600 nm reached 0.6 AU. Protein expression was induced with the addition of 100 M isopropyl 1-thio-␤ -D -galactopyranoside (Research Products, Mount Prospect, IL), at which point cells were moved to a 25°C shaker for 14 h incubation. Cells were harvested by centrifugation (2,500 g for 10 min at 4°C), and the pellet was resuspended in 20 ml of the lysis buffer (50 mM Tris, 300 mM NaCl, 10 mM imidazole, and 10% (v/v) glycerol, pH 7.9). The solution was sonicated for 5 min with 30 s intervals and centrifuged for 30 min (39,000 g at 4°C). The supernatant was transferred to a 50 ml Falcon tube a necessity for expensive instrumentation, uncertainty about the physical nature of lipids coated on the sensor chip, and binding measurements under nonequilibrium conditions. Various fl uorescence techniques have been employed to monitor membrane-protein interaction. The change in Trp fl uorescence emission intensity in terms of an increase ( 15 ) , quenching ( 16 ) , and fl uorescence resonance energy transfer ( 17, 18 ) can be monitored as a protein binds the membrane if it contains a Trp residue(s) on the membrane binding surface. Although rapid, convenient, and potentially sensitive, this method is not generally applicable because there are many membrane binding proteins without Trp on their membrane binding surfaces and because genetic introduction of Trp to the membrane binding surface can dramatically change the membrane binding property of the protein ( 19 ) . Site-specifi c incorporation of a single organic fl uorophore into a protein allows highly sensitive monitoring of membrane binding, but this method is limited by experimental inconvenience and the relatively low yield of chemical modifi cation ( 20 ) . Other fl uorescence techniques, including anisotropy ( 21 ) and fl uorescence correlation spectroscopy analyses ( 22 ) , have also been used to measure membrane-protein interaction, but their general use has been hampered by their respective drawbacks and limitations.
Most important, none of these methods allow sensitive and robust high-throughput analysis that can be universally applied to all membrane binding proteins. A recent effort to develop an immunochemical plate assay for lipid-protein binding had limited success because many membrane binding proteins cannot tightly bind the lipid molecule isolated from the membrane environment ( 23 ) . Lack of high-throughput assay greatly hampers large-scale characterization of proteins to identify new and novel membrane binding proteins and screening of small molecule libraries to identify those molecules that can effectively modulate membrane binding of pharmacologically important proteins. To overcome these technical limitations and problems, we have developed a new sensitive and robust high-throughput membrane binding assay that is based on fl uorescence quenching of enhanced green fl uorescence protein (EGFP) fused to proteins by N -dimethylaminoazobenzenesulfonyl-phosphatidylethanolamine (dabsyl-PE) incorporated in vesicles with various lipid compositions. Our results show that this simple and sensitive assay is applicable to rapid and accurate determination of lipid affi nity and specifi city of diverse proteins as well as to high-throughput screening of small molecules that can modulate membrane binding of proteins. 
MATERIALS AND METHODS

SPR analysis
All SPR measurements were performed at 23°C in 20 mM Tris-HCl, pH 7.4, containing 0.16 M NaCl using a lipid-coated L1 chip in the BIACORE X system as described previously ( 25, 26 ) . POPC/POPS/phosphoinositide (PtdIns P ) (77:20:3) vesicles and POPC vesicles were coated onto the active surface and the control surface, respectively. Equilibrium SPR measurements were done at the fl ow rate of 5 l/min to allow suffi cient time for the response in resonance units (RUs) of the association phase to reach near-equilibrium values ( R eq ). Assuming a Langmuir-type binding between the protein ( P ) and protein binding sites (M) on vesicles (i.e., P + M ↔ PM), R eq values were then plotted versus the total protein concentration ([ P ] o ), and the K d value was determined by a nonlinear least-squares analysis of the binding isotherm using an equation,
. Each data set was repeated three or more times to calculate average and standard deviation values. For kinetic SPR measurements, the fl ow rate was maintained at 15 l/min for both association and dissociation phases ( 27, 28 ) .
RESULTS AND DISCUSSION
Assay strategy
Our basic assay strategy for a universal high-throughput membrane binding assay is two-fold. First, we render comparable fl uorescence properties to all proteins by expressing them as EGFP-fusion proteins. We then quantify their membrane binding by monitoring the decrease in EGFP fl uorescence as the proteins bind the lipid vesicles incorporating a nonfl uorescent quenching dye (dark quencher) (see Fig. 1 ).
Fluorescence proteins, including EGFP, have been extensively used to monitor the subcellular localization, dynamics, and interactions of numerous cellular proteins ( 29, 30 ) . Although some fl uorescence proteins, most notably red derivatives, have been reported to induce protein oligomerization, EGFP is known to have much less effect on the structure, function, and dynamics of the parent protein in most cases when attached to either the N or C terminus of the fusion partner with an appropriate linker ( 29, 30 ) . As is the case with other fusion proteins, EGFPfusion proteins can be expressed in bacteria in high yield, as stable EGFP generally improves the expression yield of fusion partners, isolated protein domains and truncated proteins in particular. Furthermore, EGFP has high fl uorescence quantum yield and does not have detectable affi nity for cell membranes.
To test the feasibility of using EGFP-tagged proteins for our assay, we fi rst expressed and characterized various lipid binding domains as EGFP-fusion proteins. The EGFP tag was attached to either the N terminus or the C terminus, depending on the protein, as the location of the tag can affect the property of the protein in some cases. C-terminal EGFP-tagged epsin1 N-terminal homology domain (ENTH-EGFP), C-terminal EGFP-tagged Akt1 PH and 1 ml of Ni-NTA agarose (Qiagen) was added. The supernatant was allowed to incubate with the resin for ‫ف‬ 30 min at 4°C with gentle mixing. The supernatant was then poured onto a column, and the resin was washed with 50 ml of 50 mM Tris buffer, pH 7.4, containing 20 mM imidazole and another 50 ml of 50 mM Tris buffer, pH 7.4, containing 40 mM imidazole. Protein was then eluted using 50 mM Tris buffer, pH 7.4, with 300 mM imidazole. Purity of eluted protein was checked by sodium-dodecylsulfate gel electrophoresis using 18% polyacrylamide gel, and the concentration was determined using the Bradford reagents. Protein was frozen in liquid nitrogen and stored at Ϫ 80°C.
Fluorescence quenching assay
All fl uorescence quenching assays were performed using FluoroLog3 spectrofl uorometer (Horiba Scientifi c) at 25°C. Two milliliters of 100 nM protein solution in 20 mM Tris buffer, pH 7.4, containing 0.16 M NaCl was transferred to a quartz cuvette (Hellma Analytics), and the EGFP fl uorescence was excited at 460 nm and its emission spectrum was obtained. Typically, the change in emission intensity at 509 nm was monitored after incremental addition of lipid vesicle solution and 1 min incubation with gentle mixing.
Fluorescence plate reader assay
The plate reader assay was performed using the 
Data analysis
Membrane binding isotherms of proteins were analyzed assuming that each protein binds independently to a site on the vesicle surface composed of n lipids with dissociation constant K d ( 10 Fig. 1 ).
Conditions and effi ciency of the EGFP quenching assay
We fi rst measured the binding of PDK1-PH-EGFP to vesicles made of POPC/POPS/dabsyl-PE/PtdIns(3,4,5)P 3 (77-x :20: x :3) to fi nd an optimal condition for the assay. The concentration of dabsyl-PE was varied from 3 to 10 mol% with the fi xed concentrations of POPS and PtdIns(3,4,5) P 3 . Both phosphatidylserine (PS) and PtdIns(3,4,5)P 3 are necessary for membrane binding of PDK1-PH ( 31 ). The maximal quenching of the EGFP fl uorescence intensity by dabsyl-PE-containing vesicles gradually increased with the increase in its concentration in the vesicles. When dabsyl-PE = 5 mol%, the maximal quenching reached 50% of the initial intensity (see Fig. 3A ). Although a higher concentration of dabsyl-PE gave a larger degree of quenching, we decided to include 5 mol% dabsyl-PE for our assay because dabsyl-PE is an anionic lipid that may promote nonspecifi c membrane binding of cationic proteins at higher concentrations. The membrane binding isotherm ( Fig. 3B ) for PDK1-PH-EGFP was constructed from the EGFP fl uorescence quenching data and the binding parameters were calculated by the nonlinear least-squares curve fi tting using the general membrane binding equation (equation 1) ( 10 ). The binding isotherm can also be analyzed using other membrane binding models, including the membrane partitioning model ( 33 ) . The K d of PDK1-PH-EGFP for POPC/POPS/dabsyl-PE/PtdIns(3,4,5)P 3 (72:20:5:3) vesicles (see Table 1 ) was comparable to that for POPC/ POPS/PtdIns(3,4,5)P 3 ( Fig. 2A, B ) was comparable to that of untagged PDK1-PH for the same vesicles ( 31 ) . A similar trend was seen with all other EGFPtagged proteins (data not shown). Also, EGFP itself showed negligible binding to the vesicles when compared with PDK1-PH-EGFP ( Fig. 2C ) . This verifi ed the notion that EGFP fusion proteins can be used in place of untagged proteins for membrane binding analysis.
We then explored the possibility of using a synthetic lipid that can greatly change the fl uorescence emission intensity of EGFP as an EGFP-fusion protein approaches the Fig. 1 . The strategy of our fl uorescence quenching-based membrane binding assay. To the solution of an EGFP-fusion protein (e.g., PDK1-PH-EGFP) is added vesicles containing their favorite lipids (e.g., PtdIns(3,4,5)P 3 shown as a shaded hexagon) and a dark quencher, dabsyl-PE (shown in black). As the protein binds the membrane surface, the fl uorescence emission intensity of EGFP is greatly reduced due to quenching by dabsyl-PE, allowing quantitative analysis of membrane-protein interaction. ( 26 ) and PtdIns(3)P ( 35 ), respectively. For all these proteins, >50% quenching of the EGFP signal was achieved by 5 mol% dabsyl-PE-containing vesicles and the background quenching by POPC/dabsyl-PE (95:5) vesicles was negligible above the buffer control. As a negative control, we measured the binding of the C-terminal EGFP-tagged second PDZ domain of NHERF1 (NHERF1-PDZ2-EGFP) ( 6, 7 ) and EGFP, which showed no membrane binding by the SPR analysis ( Fig. 2C ) ( 31 ) . This demonstrates that lipid specifi city and affi nity of a membrane binding protein can be accurately determined by our assay.
To test the general applicability of our EGFP quenching assay, we measured the binding of three other lipid binding domains, ENTH-EGFP, Akt1-PH-EGFP, and SNX27-PX-EGFP, by the same method. As shown in Fig. 4 , all three proteins exhibited the behaviors consistent with Fig. 3 . Fluorescence quenching of the C-terminal EGFP-tagged PDK1 PH domain (PDK1-PH-EGFP) by dabsyl-PE-containing vesicles. A: Fluorescence emission spectra of PDK1-PH-EGFP (100 nM) in the presence of increasing concentrations of POPC/POPS/dabsyl-PE/PtdIns(3,4,5)P 3 (72:20:5:3) vesicles were measured in the cuvette-based assay. The total lipid concentrations used were 0, 1.6, 3.9, 5.4, 6.9, 8.5, 9.2, 10.0, and 11.6 M from top to bottom. Fluorescence emission intensity was normalized against the EGFP intensity value at 509 nm without lipid vesicles. B: Binding isotherms of PDK1-PH-EGFP with vesicles containing various PtdIns P s, i.e., POPC/POPS/dabsyl-PE/PtdIns P (72:20:5:3) vesicles. PtdIns P includes PtdIns(3,4,5)P 3 , PtdIns(3,4)P 2 , PtdIns(4,5)P 2 , PtdIns(3,5)P 2 , PtdIns(3)P, PtdIns(4)P, PtdIns(5)P, and PtdIns. POPC/dabsyl-PE (95:5) vesicles were also tested as a negative control. The fl uorescence decrease upon lipid addition was background corrected by the fl uorescence decrease upon addition of the same volume of the buffer solution. ⌬ F / ⌬ F max was calculated as fl uorescence intensity decrease at a given lipid concentration divided by the maximal fl uorescence decrease. The binding isotherm for POPC/POPS/dabsyl-PE/PtdIns(3,4,5)P 3 (72:20:5:3) vesicles was fi t by nonlinear least-squares analysis using equation 1. Values of n (40 ± 10) and K d (35 ± 10 nM) are summarized in Table 1 . lipid samples can be readily prepared, our assay allows universal high-throughput quantifi cation of lipid specifi city and affi nity of proteins. For the above four proteins, 20 mol% of PS was included in all vesicles because PS is known to enhance their membrane binding ( 26, 31, 34, 36 ) . However, in a more general nonbiased assay, one can run a two-step assay starting with POPC/dabsyl-PE/ L 1 (95-x :5: x ) ( L 1 = PS, PtdIns, cholesterol, etc.; x = 0-30 mol%) to fi rst detect any requirement for a bulk lipid and then performing a specifi city and affi nity test with POPC/dabsyl-PE/ L 1 / L 2 (75-x :5:20: x ) ( L 2 = PtdIns P , phosphatidic acid, ceramide, diacylglycerol, etc.; x = 0-10 mol%; 20 mol% is an arbitrary concentration for L 1 ). This two-step assay is preferred over a single-step assay employing, e.g., POPC/dabsyl-PE/ L (70:5:25) ( L = all lipids) because it is not physiologically meaningful to directly compare bulk lipids, such as PS or cholesterols, with signaling lipids, such as PtdIns(3,4,5)P 3 , which exist in such different concentrations in cell membranes. Also, many membrane binding proteins interact with both bulk lipids and a signaling lipid coincidently ( 2 ).
High-throughput screening of membrane binding inhibitors
Having established the conditions for the high-throughput membrane binding assay, we then tested if the assay can be used to screen molecules that can modulate the membrane binding of proteins through competition analysis. As a proof of principle, we measured the inhibitory activity of Ins(1,3,4,5)P 4 against membrane binding of PDK1-PH. Ins(1,3,4,5)P 4 is a soluble molecule that is known to be able to compete with PtdIns(3,4,5)P 3 for the lipid binding pocket of proteins ( 37 ) . Increasing concentrations (0-200 M) of Ins(1,3,4,5)P 4 were added to each row of a 96-well plate and incubated with a fi xed concentration (i.e., 100 nM) of PDK1-PH-EGFP. After increasing concentrations of its preferred lipid vesicles [i.e., POPC/POPS/dabsyl-PE/ PtdIns(3,4,5)P 3 (72:20:5:3)] were added to each row, the fi nal fl uorescence intensity readout was recorded and the maximal fl uorescence decrease in each row ( ⌬ F ) determined after background correction by the buffer solution. As shown in Fig. 6 , the analysis of the plot of ⌬ F/ ⌬ F max [ ⌬ F without Ins(1,3,4,5)P 4 ] as a function of Ins(1,3,4,5)P 4 concentration gave an IC 50 value of 150 ± 25 M. These results demonstrate the feasibility of high-throughput screening for inhibitors of membrane-protein interactions. The same method can be applied to the screening of small molecule libraries against membrane binding of any proteins. Also, the assay can be performed in a more expedited format using a single point lipid determination (e.g., a fi xed vesicle concentration giving a half-maximal quenching of EGFP in the absence of an inhibitor) instead of the multiple lipid determination described above.
CONCLUSION
We have developed a new fl uorescence-based highthroughput assay for membrane-protein binding. Its main (72:20:5:3) vesicles under the same conditions. Collectively, these results show that our EGFP quenching assay can be used universally for all membrane binding proteins.
High-throughput EGFP quenching assay
High sensitivity and signal-to-noise ratio of the EGFP quenching assay indicated that it could be used in a plate reader-based high-throughput assay. To quantitatively determine the lipid specifi city and affi nity simultaneously, we placed in each row of a 96-well plate varying concentrations of vesicles containing different lipids (i.e., POPC/ POPS/dabsyl-PE/ X (72:20:5:3); X = each of seven PtdIns P s and PtdIns) and allowed them to interact with a fi xed concentration of an EGFP-fusion protein. Two control rows contained the buffer solution and POPC/dabsyl-PE (95:5), respectively. As shown in Fig. 5 , lipid specifi city and affi nity for all four EGFP-fusion proteins, PDK1-PH-EGFP, ENTH-EGFP, Akt1-PH-EGFP, and SNX27-PX-EGFP, were determined accurately and rapidly by this 96-well plate reader assay. K d values for their binding to the preferred lipid vesicles were statistically comparable to those determined by the cuvette-based assay ( Table 1 ) . One complete assay for each protein can be completed within minutes and the total amounts of protein and lipid samples for each assay are much less than those required for other assays, including SPR analysis. Because EGFP-tagged proteins and Table 1 . ⌬ F / ⌬ F max was calculated as described for advantages are simplicity, sensitivity, speed, and a high degree of fl exibility in assay design. It is generally applicable to membrane binding analysis of any proteins (including truncated proteins), modular domains, and small motifs, because most of these proteins can be stably expressed as EGFP-fusion proteins. The assay can be further modifi ed and improved with different fl uorescence protein fusion partners and different dark quencher-containing lipids. The assay will facilitate the genomic-scale identifi cation of new and novel membrane binding proteins with unique functionality. It will also accelerate the identifi cation of small molecules that can specifi cally and potently modulate Table 1 . 
